Immunotherapy and Cancer
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Cellular Biochemistry".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 33137
Special Issue Editor
Interests: breast cancer; cancer therapeutics; Wnt signaling; PI3K/Akt signaling; hippo pathway; drug development; biomarker identification; transcription factors; sumoylation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The immune system helps the body fight infections and other diseases. Immunotherapy is a type of cancer treatment that helps the immune system combat cancer. Basic science discoveries elucidating the molecular and cellular biology of T cells have inspired the development of new strategies against cancer, including checkpoint blockade, adoptive cellular therapy and cancer vaccinology. This area of immunological research has been highly active for the past few years and is now enjoying unprecedented bench-to-bedside clinical success.
“Immunotherapy for Cancer” aims to highlight the immune and molecular profiles of tumor lesions that are needed to determine the potential predictive value of the immune landscape on immunotherapeutic responses. We encourage contributions on immune checkpoint inhibitors; T-cell transfer therapy; monoclonal antibodies; treatment vaccines; immune system modulators; biomarkers; and systematic reviews. Topics such as modulation of the tumor microenvironment and overcoming drug resistance are also welcomed.
Prof. Dr. Alan Prem Kumar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor microenvironment
- immune checkpoint inhibitors
- T-cell transfer therapy
- monoclonal antibodies
- treatment vaccines
- immune system modulators
- chemoresistance
- biomarkers